Aurora Cannabis Stock Forecast, Price & News

$9.82
-0.07 (-0.71 %)
(As of 06/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$9.69
$10.01
50-Day Range
$6.86
$10.23
52-Week Range
$3.71
$18.98
Volume3.50 million shs
Average Volume16.24 million shs
Market Capitalization$1.94 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.2
30 days | 90 days | 365 days | Advanced Chart
Receive ACB News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.


Aurora Cannabis logo

About Aurora Cannabis

Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.94 out of 5 stars

Medical Sector

1164th out of 2,099 stocks

Medicinals & Botanicals Industry

9th out of 32 stocks

Analyst Opinion: 1.8Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Aurora Cannabis (NYSE:ACB) Frequently Asked Questions

Is Aurora Cannabis a buy right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 6 sell ratings and 7 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aurora Cannabis stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View analyst ratings for Aurora Cannabis
or view top-rated stocks.

What stocks does MarketBeat like better than Aurora Cannabis?

Wall Street analysts have given Aurora Cannabis a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aurora Cannabis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Aurora Cannabis' next earnings date?

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Thursday, September 23rd 2021.
View our earnings forecast for Aurora Cannabis
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NYSE:ACB) released its earnings results on Wednesday, May, 12th. The company reported ($0.82) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.65. Aurora Cannabis had a negative trailing twelve-month return on equity of 11.19% and a negative net margin of 895.36%.
View Aurora Cannabis' earnings history
.

How has Aurora Cannabis' stock been impacted by COVID-19 (Coronavirus)?

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ACB shares have decreased by 4.7% and is now trading at $9.82.
View which stocks have been most impacted by COVID-19
.

When did Aurora Cannabis' stock split? How did Aurora Cannabis' stock split work?

Aurora Cannabis's stock reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for ACB?

13 equities research analysts have issued 12-month target prices for Aurora Cannabis' stock. Their forecasts range from $3.60 to $10.00. On average, they anticipate Aurora Cannabis' stock price to reach $7.58 in the next year. This suggests that the stock has a possible downside of 22.8%.
View analysts' price targets for Aurora Cannabis
or view top-rated stocks among Wall Street analysts.

Who are Aurora Cannabis' key executives?

Aurora Cannabis' management team includes the following people:
  • Mr. Michael Singer, Exec. Chairman (Age 56, Pay $437.41k)
  • Mr. Glen Ibbott, Chief Financial Officer
  • Mr. Allan John Cleiren C.P.A., C.A., ICD.D., Chief Operating Officer
  • Ms. Jillian Swainson, Chief Legal Officer & Corp. Sec.
  • Mr. Miguel Martin, CEO & Director (Age 49)
  • Mr. Darryl Vleeming, Exec. VP of Information Services
  • Dr. Jonathan Page Ph.D., Chief Science Officer (Age 52)
  • Ananth Krishnan, VP of Capital Markets & Investor Relations
  • Michelle Lefler, VP of Communications & PR
  • Mr. Carey Squires, Exec. VP, Corp. Devel. & Strategy

Who are some of Aurora Cannabis' key competitors?

What other stocks do shareholders of Aurora Cannabis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include (CGC), Cronos Group (CRON), (APHA), NVIDIA (NVDA), (HEXO), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

What is Aurora Cannabis' stock symbol?

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by many different retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (0.59%), TD Asset Management Inc. (0.32%), Swiss National Bank (0.21%), Point72 Asset Management L.P. (0.15%), Goldman Sachs Group Inc. (0.15%) and Renaissance Technologies LLC (0.12%).

Which institutional investors are selling Aurora Cannabis stock?

ACB stock was sold by a variety of institutional investors in the last quarter, including CIBC Asset Management Inc, CIBC World Markets Inc., BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Great West Life Assurance Co. Can, Scotia Capital Inc., Levin Capital Strategies L.P., Dimensional Fund Advisors LP, and Zurcher Kantonalbank Zurich Cantonalbank.

Which institutional investors are buying Aurora Cannabis stock?

ACB stock was acquired by a variety of institutional investors in the last quarter, including Mirae Asset Global Investments Co. Ltd., Point72 Asset Management L.P., Renaissance Technologies LLC, Royal Bank of Canada, Goldman Sachs Group Inc., Ameriprise Financial Inc., TD Asset Management Inc., and HRT Financial LP.

How do I buy shares of Aurora Cannabis?

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aurora Cannabis' stock price today?

One share of ACB stock can currently be purchased for approximately $9.82.

How much money does Aurora Cannabis make?

Aurora Cannabis has a market capitalization of $1.94 billion and generates $207.89 million in revenue each year. The company earns $-2,468,190,000.00 in net income (profit) each year or ($2.86) on an earnings per share basis.

How many employees does Aurora Cannabis have?

Aurora Cannabis employs 2,731 workers across the globe.

What is Aurora Cannabis' official website?

The official website for Aurora Cannabis is auroramj.com.

Where are Aurora Cannabis' headquarters?

Aurora Cannabis is headquartered at 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6.

How can I contact Aurora Cannabis?

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]


This page was last updated on 6/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.